Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) has spread worldwide and is also an important disease in Japan. Thus, the optimal treatment strategy for severe COVID-19 should be established urgently. The effects of combination treatment with baricitinib—a Janus kinase inhibitor, remdesivir, and dex...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumo, Takehiro, Kuse, Naoyuki, Awano, Nobuyasu, Tone, Mari, Sakamoto, Keita, Takada, Kohei, Muto, Yutaka, Fujimoto, Kazushi, Saiki, Ayae, Ito, Yu, Matsumoto, Haruko, Inomata, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352677/
https://www.ncbi.nlm.nih.gov/pubmed/34413006
http://dx.doi.org/10.1016/j.resinv.2021.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352677/
https://www.ncbi.nlm.nih.gov/pubmed/34413006
http://dx.doi.org/10.1016/j.resinv.2021.07.004

Ejemplares similares